Cardiawave Announces the Publication in The Lancet of First-In-Human Clinical Studies Results With 40 Aortic Stenosis Patients Treated With Its Innovative Non-invasive Ultrasound Therapy (NIUT)
The patients were treated with Cardiawave’s NIUT investigational device in one session.
- The patients were treated with Cardiawave’s NIUT investigational device in one session.
- “Clinically, the patients experienced a considerable improvement in their clinical status suggesting a better quality of life.
- These early findings can represent a change in the paradigm of CAS treatment especially for patients who have no other options.
- In July 2023, Cardiawave successfully completed the patient enrolment with no procedure or device-related mortality up to 30 days.